A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats - PubMed (original) (raw)
A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats
Thiruma V Arumugam et al. Kidney Int. 2003 Jan.
Free article
Abstract
Background: C5a has been implicated in numerous pathophysiological conditions, including ischemia/reperfusion (I/R) injury of the kidney. We examined whether a novel and specific C5a receptor antagonist, the cyclic compound AcF-[OPdChaWR] could moderate I/R-induced renal injury in rats.
Methods: Female Wistar rats were subjected to renal ischemia (60 min) and reperfusion (5 h). Rats were treated with either 1 mg/kg IV in 5% ethanol/saline or 10 mg/kg PO in 25% ethanol/saline prior to ischemia. I/R injury was characterized by significant tissue hemorrhage with increased microvascular permeability, elevated renal tissue levels of tumor necrosis factor-alpha (TNF-alpha) and myeloperoxidase (MPO), increased serum levels of creatinine and aspartate aminotransferase (AST) and hematuria.
Results: Pre-ischemic treatment with the C5a receptor (C5aR) antagonist (1 mg/kg IV or 10 mg/kg PO) substantially inhibited or prevented I/R-induced hematuria, vascular leakage, tissue levels of TNF-alpha and MPO, and serum levels of AST and creatinine. Histological examination of kidneys from antagonist pretreated I/R animals showed a marked reduction in tissue damage compared to drug-free I/R rats. This antagonist, however, did not inhibit complement-mediated lysis of red blood cells, suggesting unimpaired formation of the membrane attack complex (MAC).
Conclusions: The results demonstrate for the first time that a selective antagonist of both human and rat C5a receptors, given either intravenously or orally, significantly protects the kidney from I/R injury in the rat. We conclude that C5a is an important pathogenic agent in renal I/R injury, and that C5a receptor antagonists may be useful therapeutic agents for the pretreatment of anticipated renal reperfusion injury in humans.
Similar articles
- Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.
Arumugam TV, Shiels IA, Woodruff TM, Reid RC, Fairlie DP, Taylor SM. Arumugam TV, et al. J Surg Res. 2002 Apr;103(2):260-7. doi: 10.1006/jsre.2002.6369. J Surg Res. 2002. PMID: 11922743 - Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats.
Woodruff TM, Arumugam TV, Shiels IA, Reid RC, Fairlie DP, Taylor SM. Woodruff TM, et al. J Surg Res. 2004 Jan;116(1):81-90. doi: 10.1016/j.jss.2003.04.001. J Surg Res. 2004. PMID: 14732352 - Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.
Arumugam TV, Woodruff TM, Stocks SZ, Proctor LM, Pollitt S, Shiels IA, Reid RC, Fairlie DP, Taylor SM. Arumugam TV, et al. J Hepatol. 2004 Jun;40(6):934-41. doi: 10.1016/j.jhep.2004.02.017. J Hepatol. 2004. PMID: 15158333 - The role of the complement system in ischemia-reperfusion injury.
Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM. Arumugam TV, et al. Shock. 2004 May;21(5):401-9. doi: 10.1097/00024382-200405000-00002. Shock. 2004. PMID: 15087815 Review. - Intracellular pattern recognition receptors and renal ischemia.
McKay DB. McKay DB. Crit Rev Immunol. 2011;31(4):297-306. doi: 10.1615/critrevimmunol.v31.i4.20. Crit Rev Immunol. 2011. PMID: 21899512 Review.
Cited by
- Prompt Thrombo-Inflammatory Response to Ischemia-Reperfusion Injury and Kidney Transplant Outcomes.
Strandberg G, Öberg CM, Blom AM, Slivca O, Berglund D, Segelmark M, Nilsson B, Biglarnia AR. Strandberg G, et al. Kidney Int Rep. 2023 Sep 24;8(12):2592-2602. doi: 10.1016/j.ekir.2023.09.025. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106604 Free PMC article. - The Complement System in Kidney Transplantation.
Santarsiero D, Aiello S. Santarsiero D, et al. Cells. 2023 Mar 2;12(5):791. doi: 10.3390/cells12050791. Cells. 2023. PMID: 36899927 Free PMC article. Review. - Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for ex vivo delivery.
Delaura IF, Gao Q, Anwar IJ, Abraham N, Kahan R, Hartwig MG, Barbas AS. Delaura IF, et al. Front Immunol. 2022 Oct 19;13:1000172. doi: 10.3389/fimmu.2022.1000172. eCollection 2022. Front Immunol. 2022. PMID: 36341433 Free PMC article. Review. - Immune response associated with ischemia and reperfusion injury during organ transplantation.
Tang Q, Dong C, Sun Q. Tang Q, et al. Inflamm Res. 2022 Dec;71(12):1463-1476. doi: 10.1007/s00011-022-01651-6. Epub 2022 Oct 25. Inflamm Res. 2022. PMID: 36282292 Free PMC article. Review. - Role of Complement System in Kidney Transplantation: Stepping From Animal Models to Clinical Application.
Qi R, Qin W. Qi R, et al. Front Immunol. 2022 Feb 25;13:811696. doi: 10.3389/fimmu.2022.811696. eCollection 2022. Front Immunol. 2022. PMID: 35281019 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous